| [1] |
Siegel RL，Miller KD，Fuchs HE，et al. Cancer Statistics，2021［J］. CA Cancer J Clin，2021，71（1）：7-33.
|
| [2] |
Zheng A，Guo BL，Zhang JG，et al. Clinical information and management status of de novo stage Ⅳ breast cancer patients：a Chinese multicenter investigation（CSBrS-002）［J］. Chin Med J（Engl），2021，134（13）：1569-1575.
|
| [3] |
Malmgren JA，Mayer M，Atwood MK，et al. Differential presentation and survival of de novo and recurrent metastatic breast cancer over time：1990-2010［J］. Breast Cancer Res Treat，2018，167（2）：579-590.
|
| [4] |
Giuliano AE，Edge SB，Hortobagyi GN. Eighth Edition of the AJCC Cancer Staging Manual：Breast Cancer［J］. Ann Surg Oncol，2018，25（7）：1783-1785.
|
| [5] |
国家肿瘤质控中心乳腺癌专家委员会，中国抗癌协会乳腺癌专业委员会，中国抗癌协会肿瘤药物临床研究专业委员会. 中国晚期乳腺癌规范诊疗指南（2020版）［J］. 中华肿瘤杂志，2020，42（10）：781-797.
|
| [6] |
Gradishar WJ，Moran MS，Abraham J，et al. NCCN Guidelines® Insights：Breast Cancer，Version 4.2021［J］. J Natl Compr Canc Netw，2021，19（5）：484-493.
|
| [7] |
Tagliafico AS，Piana M，Schenone D，et al. 2020. Overview of radiomics in breast cancer diagnosis and prognostication［J］. Breast，49：74-80.
|
| [8] |
Zheng C，Yu ZG. Clinical practice guidelines for pre-operative evaluation of breast cancer：Chinese Society of Breast Surgery（CSBrS）practice guidelines 2021［J］. Chin Med J（Engl），2021，134（18）：2147-2149.
|
| [9] |
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会（CSCO）乳腺癌诊疗指南2021［M］. 北京：人民卫生出版社，2021.
|
| [10] |
Expert Panel on Breast Imaging，Slanetz PJ，Moy L，et al. ACR Appropriateness Criteria（®）Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer［J］. J Am Coll Radiol，2017，14（11S）：S462-S475.
|
| [11] |
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤（CSCO）中枢神经系统转移性肿瘤诊疗指南2021［M］，北京：人民卫生出版社，2021.
|
| [12] |
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范（2021年版）［J］. 中国癌症杂志，2021，31（10）：954-1040.
|
| [13] |
Constantinidou A，Martin A，Sharma B，et al. Positron emission tomography/computed tomography in the management of recurrent/metastatic breast cancer：a large retrospective study from the Royal Marsden Hospital［J］. Ann Oncol，2011，22（2）：307-314.
|
| [14] |
Eubank WB，Mankoff D，Bhattacharya M，et al. Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer［J］. AJR Am J Roentgenol，2004，183（2）：479-486.
|
| [15] |
向泓雨，刘倩，刘荫华. 2021版《中华医学会乳腺外科临床实践指南》重点内容解读［J］. 中国实用外科杂志，2021，41（11）：1257-1261.
|
| [16] |
Tarantino P，Gandini S，Nicolò E，et al. 2022. Evolution of low HER2 expression between early and advanced-stage breast cancer［J］. Eur J Cancer，163：35-43.
|
| [17] |
Modi S，Jacot W，Yamashita T，et al. 2022. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer［J］. N Engl J Med，387：9-20.
|
| [18] |
Robson ME，Tung N，Conte P，et al. OlympiAD final overall survival and tolerability results：Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer［J］. Ann Oncol，2019，30（4）：558-566.
|
| [19] |
Jr Geyer CE，Garber JE，Gelber RD，et al. 2022. Overall survival in the OlympiA phase Ⅲ trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk，early breast cancer［J］. Ann Oncol，2022，33（12）：1250-1268.
|
| [20] |
向泓雨，刘荫华. 2022年《中华医学会乳腺外科临床实践指南》更新解读［J］. 中国肿瘤外科杂志，2022，14（03）：219-223.
|
| [21] |
Price DD，Mcgrath PA，Rafii A，et al. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain［J］. Pain，1983，17（1）：45-56.
|
| [22] |
lane WO，thomas SM，blitzblau RC，et al. Surgical Resection of the Primary Tumor in Women With De Novo Stage Ⅳ Breast Cancer：Contemporary Practice Patterns and Survival Analysis［J］. Ann Surg，2019，269（3）：537-544.
|
| [23] |
Si Y，Yuan P，Hu N，et al. Primary Tumor Surgery for Patients with De Novo Stage Ⅳ Breast Cancer can Decrease Local Symptoms and Improve Quality of Life［J］. Ann Surg Oncol，2020，27（4）：1025-1033.
|
| [24] |
Soran A，Ozmen V，Ozbas S，et al. Primary Surgery with Systemic Therapy in Patients with de Novo Stage Ⅳ Breast Cancer：10-year Follow-up；Protocol MF07-01 Randomized Clinical Trial［J］. J Am Coll Surg，2021，233（6）：742-751.e5.
|
| [25] |
King TA，Lyman JP，Gonen M，et al. Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage Ⅳ Breast Cancer：TBCRC 013［J］. J Clin Oncol，2016，34（20）：2359-2365.
|
| [26] |
Khan SA，Zhao F，Goldstein LJ，et al. Early Local Therapy for the Primary Site in De Novo Stage Ⅳ Breast Cancer：Results of a Randomized Clinical Trial（EA2108）［J］. J Clin Oncol，2022，40（9）：978-987.
|
| [27] |
Rao R，Feng L，Kuerer HM，et al. Timing of surgical intervention for the intact primary in stage Ⅳ breast cancer patients［J］. Ann Surg Oncol，2008，15（6）：1696-1702.
|
| [28] |
Ruiterkamp J，Ernst MF，van de Poll-Franse LV，et al. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis［J］. Eur J Surg Oncol，2009，35（11）：1146-1151.
|
| [29] |
Pathy NB，Verkooijen HM，Taib NA，et al. Impact of breast surgery on survival in women presenting with metastatic breast cancer［J］. Br J Surg，2011，98（11）：1566-1572.
|
| [30] |
Rapiti E，Verkooijen HM，Vlastos G，et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis［J］. J Clin Oncol，2006，24（18）：2743-2749.
|
| [31] |
Cardoso F，Paluch-Shimon S，Senkus E，et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer（ABC 5）［J］. Ann Oncol，2020，31（12）：1623-1649.
|
| [32] |
Friedel G，Pastorino U，Ginsberg RJ，et al. Results of lung metastasectomy from breast cancer：prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases［J］. Eur J Cardiothorac Surg，2002，22（3）：335-344.
|
| [33] |
Abbott DE，Brouquet A，Mittendorf EA，et al. Resection of liver metastases from breast cancer：estrogen receptor status and response to chemotherapy before metastasectomy define outcome［J］. Surgery，2012，151（5）：710-716.
|
| [34] |
Bilani N，Yaghi M，Main O，et al. Metastasectomy versus radiation of secondary sites in stage Ⅳ breast cancer：Analysis from a national cancer registry［J］. Breast，2021，60：185-191.
|
| [35] |
Fan J，Chen D，Du H，et al. Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients：a systematic review and meta-analysis［J］. J Thorac Dis，2015，7（8）：1441-1451.
|
| [36] |
Feng Y，He XG，Zhou CM，et al. Comparison of hepatic resection and systemic treatment of breast cancer liver metastases：A propensity score matching study［J］. Am J Surg，2020，220（4）：945-951.
|
| [37] |
Ercolani G，Zanello M，Serenari M，et al. Ten-Year Survival after Liver Resection for Breast Metastases：A Single-Center Experience［J］. Dig Surg，2018，35（4）：372-380.
|
| [38] |
Magnoni F，Colleoni M，Mattar D，et al. Contralateral Axillary Lymph Node Metastases from Breast Carcinoma：Is it Time to Review TNM Cancer Staging？［J］. Ann Surg Oncol，2020，27（11）：4488-4499.
|
| [39] |
Ai X，Wang M，Li J，et al. Supraclavicular lymph node dissection with radiotherapy versus radiotherapy alone for operable breast cancer with synchronous ipsilateral supraclavicular lymph node metastases：a real-world cohort study［J］. Gland Surg，2020，9（2）：329-341.
|
| [40] |
张薇，齐晓敏，陈翱翔，等. 锁上淋巴结清扫在初诊伴锁上淋巴结转移乳腺癌患者治疗中的作用［J］. 中华肿瘤杂志，2017，39（05）：374-379.
|
| [41] |
Gnerlich J，Jeffe DB，Deshpande AD，et al. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer：analysis of the 1988-2003 SEER data［J］. Ann Surg Oncol，2007，14（8）：2187-2194.
|
| [42] |
Khan SA，Stewart AK，Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer？［J］. Surgery，2002，132（4）：620-626；discussion 6-7.
|
| [43] |
Lian CL，Guo LY，Zhang L，et al. Aggressive Local Treatment Improves Survival in Stage Ⅳ Breast Cancer With Synchronous Metastasis［J］. Front Oncol，2020，10：522580.
|
| [44] |
Pons-Tostivint E，Kirova Y，Lusque A，et al. Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis［J］. Radiother Oncol，2020，145：109-116.
|
| [45] |
Viani GA，Gouveia AG，Louie AV，et al. Stereotactic body radiotherapy to treat breast cancer oligometastases：A systematic review with meta-analysis［J］. Radiother Oncol，2021，164：245-250.
|
| [46] |
向泓雨，刘荫华. 制定高质量临床实践指南推动中国乳腺外科诊治规范化进程［J/CD］. 中华普外科手术学杂志（电子版），2022，16（02）：119-122.
|
| [47] |
张毅，万安第. 开展中国乳腺外科腔镜手术多中心研究的思考［J/CD］. 中华普外科手术学杂志（电子版），2022，16（02）：127-131.
|